BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29399192)

  • 1. Comparison of the expression of TGF-β1, E-cadherin, N-cadherin, TP53, RB1CC1 and HIF-1α in oral squamous cell carcinoma and lymph node metastases of humans and mice.
    Guo M; Mu Y; Yu D; Li J; Chen F; Wei B; Bi S; Yu J; Liang F
    Oncol Lett; 2018 Feb; 15(2):1639-1645. PubMed ID: 29399192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of hypoxia-inducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma].
    Li JN; Feng ZE; Wang L; Wang YX; Guo CB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):26-32. PubMed ID: 29483718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression levels of MMP-14, ING4 and HIF-1α in 60 patients with oral squamous cell carcinoma and their clinical significance].
    Fu ZY; Tao F
    Shanghai Kou Qiang Yi Xue; 2020 Dec; 29(6):642-646. PubMed ID: 33778834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
    Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional significance of TGF-beta1 signal transduction pathway in oral squamous cell carcinoma].
    Wang XM; Liu CM; Zhang CR; Xu XG; Fu SB
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):28-32. PubMed ID: 19538865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression of E-cadherin, vimentin, β-catenin, transforming growth factor-β1 in oral squamous cell carcinomas].
    Zhang L; Lu Z; Yin C; Xia M; Xie S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Apr; 50(4):228-34. PubMed ID: 26081960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway.
    Naruse T; Kawasaki G; Yanamoto S; Mizuno A; Umeda M
    Anticancer Res; 2011 Dec; 31(12):4429-37. PubMed ID: 22199311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
    Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
    Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
    Ma C; Zhao JZ; Lin RT; Zhou L; Chen YN; Yu LJ; Shi TY; Wang M; Liu MM; Liu YR; Zhang T
    Oncol Lett; 2018 Jun; 15(6):9498-9506. PubMed ID: 29805672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia disrupt tight junctions and promote metastasis of oral squamous cell carcinoma via loss of par3.
    Kim S; Park S; Moon EH; Kim GJ; Choi J
    Cancer Cell Int; 2023 Apr; 23(1):79. PubMed ID: 37095487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Iwata E; Hasegawa T; Takeda D; Ueha T; Kawamoto T; Akisue T; Sakai Y; Komori T
    Int J Oncol; 2016 Apr; 48(4):1493-8. PubMed ID: 26846904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features.
    Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the correlation of the expression level of hypoxia-inducible factor-1α with the glycosylation of oral squamous cell carcinoma.
    Xu X; Liu H; Wu R; Zuo W; Wang T; Chen D
    Am J Transl Res; 2021; 13(6):6686-6693. PubMed ID: 34306413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma.
    Aga M; Kondo S; Wakisaka N; Moriyama-Kita M; Endo K; Nakanishi Y; Murono S; Sugimoto H; Ueno T; Yoshizaki T
    Auris Nasus Larynx; 2017 Apr; 44(2):213-219. PubMed ID: 27616748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.
    Abouhashem NS; Ibrahim DA; Mohamed AM
    Ann Diagn Pathol; 2016 Jun; 22():1-11. PubMed ID: 27180053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.
    Zhou J; Huang S; Wang L; Yuan X; Dong Q; Zhang D; Wang X
    World J Surg Oncol; 2017 May; 15(1):104. PubMed ID: 28521842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia inducible factor-1α expression in areca quid chewing-associated oral squamous cell carcinomas.
    Lee SS; Tsai CH; Yang SF; Ho YC; Chang YC
    Oral Dis; 2010 Oct; 16(7):696-701. PubMed ID: 20846156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study.
    Kalaimani G; Rao UDK; Joshua E; Ranganathan K
    Cureus; 2023 Aug; 15(8):e44266. PubMed ID: 37772225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.
    Sato J; Kitagawa Y; Yamazaki Y; Hata H; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
    J Nucl Med; 2013 Jul; 54(7):1060-5. PubMed ID: 23699668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.